Exchange: NASDAQ·Updated 03:02 PM EDT
AUTL logo

AUTL Autolus Therapeutics Ltd - ADR

$2.25
$0.045
(1.97%)
Today
Reported EarningsAug 11
Mkt Cap$609.51M
Vol1.29M

About AUTL

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
31

Bearish Sentiment

How do you feel about AUTL?

Advertisement|Remove ads.